SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-105574
Filing Date
2021-08-16
Accepted
2021-08-16 07:20:32
Documents
3
Group Members
HUTCHISON CHINA MEDITECH INVESTMENT LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2125083d1_sc13d.htm SC 13D 79891
2 EXHIBIT 99.1 tm2125083d1_ex99-1.htm EX-99.1 111302
3 EXHIBIT 99.2 tm2125083d1_ex99-2.htm EX-99.2 7543
  Complete submission text file 0001104659-21-105574.txt   200501
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87481 | Film No.: 211174491
SIC: 2834 Pharmaceutical Preparations

Mailing Address 48TH FLOOR, CHEUNG KONG CENTER 2 QUEEN'S ROAD CENTRAL HONG KONG K3 00000
Business Address 48TH FLOOR, CHEUNG KONG CENTER 2 QUEEN'S ROAD CENTRAL HONG KONG K3 00000 852-2121-3888
HUTCHMED (China) Ltd (Filed by) CIK: 0001648257 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations